Skip to main content
Log in

Polymorphism and pseudopolymorphism of acyclovir

  • Articles
  • Drug Development
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Four crystal modifications of acyclovir were isolated by recrystallization and characterized by powder X-ray diffractometry, differential scanning calorimetry, and thermogravimetric analysis. It was confirmed that Form 3 is a hydrate and Form 4 is an acetic acid solvate. The dissolution patterns of three crystal forms of acyclovir were studied in water at 37±0.5°C, 90 rpm for 120 minutes. The amount dissolved at 120 minutes was highest for Form 1, followed by Form 2 and Form 3. After storage of 25 hours at 0% RH (silica gel, 20°C) Form 3 was transformed to Form 2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Balfour, H. H., Drug therapy: Antiviral drugs, Review. N. Engl. J. Med., 340, 1255–1268 (1999).

    Article  PubMed  CAS  Google Scholar 

  • Giron, D., Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates. Thermochim. Acta, 248, 1–59 (1995).

    Article  CAS  Google Scholar 

  • Grünenberg, A., Polymorphie und thermische Analyse pharmazeutischer Wirkstoffe. Pharmazie in unserer Zeit, 26, 224–231 (1997).

    Article  PubMed  Google Scholar 

  • Haleblian, J. K., Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci., 64, 1269–1288 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Haleblian, J. K. and McCrone, W. C., Pharmaceutical applications of polymorphism. J. Pharm. Sci., 58, 911–929 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Higuchi, W. I., Lau, P. K., Higuchi, T., and Shell, J. W., Polymorphism and drug availability, solubility relations in the methylprednisolone system. J. Pharm. Sci., 52, 150–153 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Hüttenrauch, R., Fundamentals of Pharmaceutics. Acta Pharm. Technol., 34, 1–10 (1988).

    Google Scholar 

  • Kristl, A., Srcic, S., Vrecer, F., Sustar, B., and Vojnovic, D., Polymorphism and pseudopolymorphism: influencing the dissolution properties of the guanine derivative acyclovir. Int. J. Pharm., 139, 231–235 (1996).

    Article  CAS  Google Scholar 

  • Kuhnert-Brandstätter, M., Polymorphie von Arzneistoffen und ihre Bedeutung in der pharmazeutischen Technologie. Informationsdienst A.P.V., 19, 73–90 (1973).

    Google Scholar 

  • Kuhnert-Brandstätter, M. and Lehner, G., Differentialthermoanalyse und IR-spektroskopische Untersucungen von Arzneistoffen, die als Hydrate vorliegen. Sci. Pharm., 52, 267–279 (1984).

    Google Scholar 

  • Shefter, E. and Higuchi, T., Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals. J. Pharm. Sci., 52, 781–791 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Sohn, Y. T., Effect of crystal form on bioavailability. J. Kor. Pharm. Sci., 34, 443–452 (2004).

    Article  CAS  Google Scholar 

  • Zupancic, V., Ograjsek, N., Kotar-Jordan, B. and Vrecer, F., Physical characterization of pantoprazole sodium hydrates. Int. J. Pharm., 291, 59–68 (2005).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young Taek Sohn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sohn, Y.T., Kim, S.H. Polymorphism and pseudopolymorphism of acyclovir. Arch. Pharm. Res. 31, 231–234 (2008). https://doi.org/10.1007/s12272-001-1146-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-001-1146-x

Key words

Navigation